Insider Trading & Ownership - Burrows Scott L

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Burrows Scott L
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-03
Sale
2024-09-05
4:04 pm
Spyre Therapeutics Inc.SYREBurrows Scott L
Chief Financial Officer
18,531$28.17$522,074116,422
(Direct)
View
2023-03-06
Sale
2023-03-08
4:29 pm
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
291$15.26$4,44259,115
(Direct)
View
2023-02-28
Sale
2023-03-02
7:05 pm
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
1,850$15.9$29,42138,406
(Direct)
View
2022-03-04
Sale
2022-03-07
8:49 pm
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
303$16.85$5,10470,556
(Direct)
View
2022-03-01
Sale
2022-03-03
4:17 pm
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
420$17.75$7,45622,259
(Direct)
View
2021-12-27
Sale
2021-12-28
5:00 pm
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
12,560$20.07$252,13922,679
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-02
8:27 pm
N/A
2034-02-01
Spyre Therapeutics Inc.SYREBurrows Scott L
Chief Financial Officer
70,000$070,000
(Direct)
View
2023-12-22
Option Award
2023-12-22
6:00 pm
N/A
N/A
Spyre Therapeutics Inc.SYREBurrows Scott L
Chief Financial Officer
134,953$0134,953
(Direct)
View
2023-09-01
Option Award
2023-09-05
4:10 pm
N/A
2033-09-01
Aeglea BioTherapeutics Inc.AGLEBurrows Scott L
Chief Financial Officer
10,121,441$010,121,441
(Direct)
View
2023-03-02
Option Award
2023-03-06
6:58 pm
N/A
2033-03-02
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
76,800$0115,206
(Direct)
View
2022-09-16
Exercise
2022-09-20
4:37 pm
N/A
2029-06-11
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
5,000$077,533
(Direct)
View
2022-09-16
Exercise
2022-09-20
4:37 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
5,000$1.680677,533
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:49 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
48,600$070,556
(Direct)
View
2021-12-30
Option Award
2022-01-04
9:05 pm
N/A
2031-08-23
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
55,704$055,704
(Direct)
View
2021-04-01
Option Award
2021-04-05
6:50 pm
N/A
2031-04-01
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
23,000$023,000
(Direct)
View

Ownership
2021-04-05
6:49 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTBurrows Scott L
Chief Financial Officer
0$097,012
(Direct)
View